She was probably told that if Susan Bayh, who was on the board of directors of NWBO AND was diagnosed with glioblastoma, opted for immunotherapy treatment at Duke and not dendritic cell treatment at UCLA, she shouldn't bother as those actions speak for themselves.
Doctors recommend SOC unless the patient pushes them in another direction. If a doctor recommends something other than the SOC that put them in legal jeopardy. Now let’s talk about a prominent person. This puts the doctor more at risk for malpractice. After MHRA approval things will change slightly. The doctor can say, “this treatment is approved in the UK” they could also export the tumor off to the UK to create the vaccine. This assumes the patient has 200K to pay for the vaccine. Even if you have to go to the UK to get the vaccine, it’s an option. For many patients, the 200k is not an issue.